| Primary information |
|---|
| sequence ID | Seq_5755 |
| Peptide sequence | NRGDSTFESKSY |
| CancerPDF_ID | CancerPDF_ID1234, CancerPDF_ID8515, CancerPDF_ID9732, |
| PMID | 21136997,23667664,21533267 |
| Protein Name | Fibrinogen alpha,Fibrinogen alpha,Fibrinogen alpha chain |
| UniprotKB Entry Name | FIBA_HUMAN,FIBA_HUMAN,FIBA_HUMAN |
| Fluid | Serum,Serum,Serum |
| M/Z | 1389.61607,1389.62,464.2 |
| Charge | 1,1,3 |
| Mass (in Da) | NA,1391.44,NA |
| fdr | NA,NA,NA |
| Profiling Technique | LC-MS,MALDI-TOF,LC-MS |
| Peptide Identification technique | LC-MS-MS/MS,FT-ICR MS/MS + nano-HPLC,LC/MS/MS |
| Quantification Technique | LC-ESI-MS,NA,Multiple Reaction Monitoring |
| Labelled/Label Free | Label Free,Label Free,Label Free |
| FDR | NA,NA,1.49 |
| CancerPDF_ID | CancerPDF_ID1234, CancerPDF_ID8515, CancerPDF_ID9732, |
| p-Value | NA,NA,NA |
| Software | MASCOT(v. 2.2.01),MASCOT,MASCOT |
| Length | 12,12,12 |
| Cancer Type | Colorectal cancer,"Breast cancer, Lung cancer, Rectal cancer",Lung adenocarcinoma |
| Database | SwissProt Database,NA,Swissprot Database (57.4) |
| Modification | NA,NA,NA |
| Number of Patients | 30 patients and 30 healthy controls,"Breast Cancer =84, lung cancer= 70, Rectal cancer = 30patients; 500 healthy",62 lung adenocarcinoma and 30 healthy control |
| Regulation | NA,NA,"Differentially expressed between earlier-stage lung cancer group (stage-I, II, and IIIa) vs normal" |
| Validation | Leave One out Cross validation,NA,MRM-based validation of 19 candidates |
| Sensitivity | NA,NA,NA |
| Specificity | NA,NA,NA |
| Accuracy | NA,NA,NA |
| Peptide Atlas | PeptideAtlas |
| IEDB | 139616 |